Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-07-229839
Filing Date
2007-10-31
Accepted
2007-10-30 18:07:30
Documents
2
Effectiveness Date
2007-10-31

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ddefa14a.htm DEFA14A 21857
2 GRAPHIC g67723g40z83.jpg GRAPHIC 11254
  Complete submission text file 0001193125-07-229839.txt   39174
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: DEFA14A | Act: 34 | File No.: 000-04829 | Film No.: 071200696
SIC: 2836 Biological Products, (No Diagnostic Substances)